AEterna Zentaris (AEZS) Rating Lowered to Hold at Zacks Investment Research

Share on StockTwits

AEterna Zentaris (NASDAQ:AEZS) (TSE:AEZ) was downgraded by Zacks Investment Research from a “buy” rating to a “hold” rating in a research note issued on Friday.

According to Zacks, “AEterna Zentaris Inc. is a biopharmaceutical company focused on endocrine therapy and oncology. Its lead endocrinology program is a Phase 3 trial in benign prostatic hyperplasia (BPH) with cetrorelix, an LHRH antagonist already marketed for in vitro fertilization under the brand name Cetrotide. The lead oncology program is a Phase 2 trial in endometrial and ovarian cancer with AEZS-108, a targeted cytotoxic peptide conjugate. Other lead compounds include ozarelix for BPH and prostate cancer as well as perifosine for multiple cancers. “

AEZS has been the subject of a number of other research reports. HC Wainwright reaffirmed a “buy” rating on shares of AEterna Zentaris in a research report on Thursday, January 17th. ValuEngine raised shares of AEterna Zentaris from a “hold” rating to a “buy” rating in a research report on Saturday, February 2nd. Finally, Maxim Group set a $2.00 price objective on shares of AEterna Zentaris and gave the company a “buy” rating in a research report on Thursday, December 20th. One analyst has rated the stock with a hold rating and three have assigned a buy rating to the stock. The stock presently has a consensus rating of “Buy” and a consensus price target of $2.67.

Shares of AEZS traded down $0.02 during trading hours on Friday, reaching $3.96. 7,768 shares of the company traded hands, compared to its average volume of 339,464. The firm has a market capitalization of $64.12 million, a P/E ratio of -2.93 and a beta of 1.23. AEterna Zentaris has a 1-year low of $1.12 and a 1-year high of $4.39.

Large investors have recently bought and sold shares of the stock. Acadian Asset Management LLC raised its position in AEterna Zentaris by 27.2% in the fourth quarter. Acadian Asset Management LLC now owns 45,049 shares of the biopharmaceutical company’s stock worth $133,000 after purchasing an additional 9,640 shares in the last quarter. Virtu Financial LLC acquired a new position in AEterna Zentaris in the third quarter worth about $101,000. O Shaughnessy Asset Management LLC acquired a new position in AEterna Zentaris in the fourth quarter worth about $66,000. Finally, Jane Street Group LLC acquired a new position in AEterna Zentaris in the fourth quarter worth about $30,000. 15.31% of the stock is owned by hedge funds and other institutional investors.

AEterna Zentaris Company Profile

Aeterna Zentaris Inc, a specialty biopharmaceutical company, engages in developing and commercializing pharmaceutical therapies for treating oncology, endocrinology, and women's health. Its commercial product is the Macrilen, a ghrelin receptor agonist that stimulates the secretion of growth hormone by binding to the GHSR-1a, a ghrelin receptor, which is used for endocrinology and oncology indications.

Read More: SEC Filing

Get a free copy of the Zacks research report on AEterna Zentaris (AEZS)

For more information about research offerings from Zacks Investment Research, visit Zacks.com

Receive News & Ratings for AEterna Zentaris Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for AEterna Zentaris and related companies with MarketBeat.com's FREE daily email newsletter.



Latest News

Trecora Resources  Major Shareholder Sells $61,530.00 in Stock
Trecora Resources Major Shareholder Sells $61,530.00 in Stock
nDEX  Price Reaches $0.0000 on Top Exchanges
nDEX Price Reaches $0.0000 on Top Exchanges
Grand City Properties  Given a €22.50 Price Target by Goldman Sachs Group Analysts
Grand City Properties Given a €22.50 Price Target by Goldman Sachs Group Analysts
Great Lakes Advisors LLC Acquires Shares of 327,057 Federated Investors Inc
Great Lakes Advisors LLC Acquires Shares of 327,057 Federated Investors Inc
Seizert Capital Partners LLC Decreases Stake in TEGNA Inc.
Seizert Capital Partners LLC Decreases Stake in TEGNA Inc.
Evertec Inc  Holdings Trimmed by Seizert Capital Partners LLC
Evertec Inc Holdings Trimmed by Seizert Capital Partners LLC


© 2006-2019 Ticker Report